Company intelligence / Profile preview

OWP Pharmaceuticals

Ownership: Private
Development stage: Commercial

Overview

OWP Pharmaceuticals is a commercial-stage neuroscience specialty pharmaceutical company focused on developing and commercializing novel oral liquid formulations of established CNS drugs. The company has FDA-approved products on the market and several pipeline candidates in early clinical or IND stages. Its business model includes donating profits to the ROW Foundation to support neurological care in under-resourced regions.

Therapeutic areas: PsychiatryNeurology
Modalities: Small molecules (oral liquid and tablet formulations)
Industry: Biotech

Drug pipeline

7 assets

OWP-107

Preclinical

6 more assets in the full pipeline.

Partnerships

EVERSANA – commercialization partnership for oral liquid neuroscience formulations in the U.S.

Beyond the preview

Go deeper on OWP Pharmaceuticals.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OWP Pharmaceuticals.